Information about EPMT
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0685.431.593

VAT liability
Yes
Established
28-11-2017
Last balance sheet year
2024
Company size
Micro 1,2 FTE
Full name
Europharmedtech
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from EPMT

2024 2023 2022 2021
Profit/Loss -53,223 -171 % 75,401 77 % 42,597 1420 % 2,803
Equity 41,127 -56 % 94,350 398 % 18,949 465 % 3,353
Gross margin 10,453 -94 % 178,395 44 % 123,995 110 % 58,908
Employees 1.2 1.2 1.1 1

Publications from EPMT

Date Publication
23-03-2023 Modification Legal Form - Resignations, Appointments (FR)
17-04-2020 Resignations, Appointments (FR)
30-11-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Europharmedtech?
The VAT number of Europharmedtech is BE 0685.431.593.
Wat is the PEPPOL ID of Europharmedtech?
The PEPPOL ID of Europharmedtech is 0208:0685431593. Log in or start a free trial to see the full overview.
When was Europharmedtech founded?
Europharmedtech was founded on 28-11-2017.
What is the address of Europharmedtech?
The current registered office of Europharmedtech is located at Avenue Charles-Quint 400/7, 1083 Ganshoren.
When was the last time Europharmedtech filed their annual financial statements?
The most recent financial statements of Europharmedtech were filed on 14-07-2025.
How many employees does Europharmedtech have?
There are 1,2 FTEs working at Europharmedtech according to the staff figures in the most recent financial statements.
What is the annual turnover of Europharmedtech?
At the time of its most recent financial statements, Europharmedtech did not publish any turnover figures. Europharmedtech reported a gross margin of €10,453.07.